La Crosse Tribune6h
Development of an mRNA vaccine for Covid-19 was fast
Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...
Moderna (MRNA) Receives a Hold from Bernstein
In a report released yesterday, Courtney Breen from Bernstein maintained a Hold rating on Moderna (MRNA – Research Report), with a price target ...
CounterPunch10h
RFK Jr. and the Science of Misinformation
The following first ran on CounterPunch at the height of the COVID pandemic in January of 2022. Are anti-vaccine ...
Politifact19h
No, Pfizer didn’t release a new list of COVID-19 vaccine side effects
"Pfizer just released its list of side effects of its COVID-19 vaccine," multiple Facebook posts said Jan. 26 and 27. The posts included a purported list of 46 Pfizer-BioNtech COVID-19 vaccine side ...
Hosted on MSN20h
Shionogi’s RSV antiviral reduces viral load in Phase II human challenge trial
Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw some participants achieving an 88.94% reduction in viral load. The Japanese ...
A Study Retracted 15 Years Ago Continues to Threaten Childhood Vaccines
"Influential people are once again twisting the truth about vaccines for their own gain," writes Eleanor Menzin.